Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
09-May-25 | Sell | Gerard Rabbette | 279.12p | 200,000 | £558,233.96 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
09-May-25 | Sell | Gerard Rabbette | 279.12p | 200,000 | £558,233.96 |
Notifier | Holding | Value* |
---|---|---|
Gerard Rabbette | 7,600,107 | £21,888,308 |
Timothy Dolphin | 5,804,691 | £16,717,510 |
Maurice Pratt | 1,179,224 | £3,396,165 |
Paul Hogan | 150,098 | £432,282 |
Notifier** | Holding | Value* |
---|---|---|
Allianz Global Investors GmbH | 34,661,426 | £99,824,907 |
Allianz Global Investors GmbH | 32,795,567 | £94,451,233 |
Allianz Global Investors GmbH | 32,520,107 | £93,657,908 |
Polar Capital | 20,743,310 | £59,740,733 |
Sisk family (same as ROI Healthco IOM I Limited) | 16,152,373 | £46,518,834 |
Allianz SE | 13,700,000 | £39,456,000 |
ROI Healthco IOM 1 Limited | 12,672,337 | £36,496,331 |
Swedbank Robur Fonder AB | 10,933,369 | £31,488,103 |
Mackenzie Investment | 10,304,698 | £29,677,530 |
Amundi Asset Management | 8,317,169 | £23,953,447 |
BlackRock, Inc. | 8,278,245 | £23,841,346 |
Allianz Global Investors GmbH | 8,207,000 | £23,636,160 |
Currency | UK Pounds |
Share Price | 288.00p |
Change Today | -2.00p |
% Change | -0.69 % |
52 Week High | 299.83 |
52 Week Low | 165.00 |
Volume | 149,427 |
Shares Issued | 259.57m |
Market Cap | £747.57m |
RiskGrade | 192 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 24-Apr-25 | 12-Sep-24 |
Paid | 16-May-25 | 04-Oct-24 |
Amount | 1.25¢ | 0.67¢ |
Time | Volume / Share Price |
14:48 | 40,000 @ 286.00p |
11:59 | 50,000 @ 290.50p |
11:11 | 6,500 @ 291.70p |
11:10 | 7,500 @ 291.50p |
12:07 | 101 @ 296.40p |
CEO | Gerard Rabbette |
CFO | Timothy Dolphin |
You are here: research